January 24, 2011
First Senate Judiciary Committee hearing of 112th Congress to focus on fraud enforcement
The chairman of the Senate Judiciary Committee, Patrick Leahy (D-Vt.), has announced his intention to focus on fraud enforcement in a hearing that will be held on January 26. The hearing, entitled “Protecting...
Posted In Whistleblower Law Insights
January 19, 2011
Whistleblower case alleges NYC overbilled Medicare by tens of millions of dollars
In an unfolding whistleblower case, the federal government has accused New York City of overbilling Medicaid by “at least tens of millions of dollars.” The complaint alleges excessive and improper...
Posted In Whistleblower Law Insights
January 19, 2011
Government contractor to pay $6.25 million to settle False Claims Act violation
Fastenal Company, a national hardware distributor, has agreed to pay $6.25 million to settle allegations that it violated terms related to a contract with the US General Services Administration (GSA)....
Posted In Whistleblower Law Insights
December 23, 2010
Medicare billing confidentiality allows huge fraud to persist
A recent article in The Wall Street Journal suggests that the confidentiality of doctors’ Medicare billing practices has allowed for instances of enormous fraud and abuse to go unchecked. The article...
Posted In Whistleblower Law Insights
December 21, 2010
Dey is fourth drug maker to settle inflated price fraud this month
Dey, a pharmaceutical manufacturer, has become the fourth drug maker this month to settle allegations involving reporting false and inflated drug prices. Payment from the Medicare and Medicaid programs...
Posted In Whistleblower Law Insights
December 20, 2010
Three drug companies pay $421 million to settle FCA suits
December has been a significant month in terms of False Claims Act recoveries from pharmaceutical companies. Three drug makers – Abbott Laboratories Inc., Roxane Laboratories Inc. and B. Braun Medical...
Posted In Whistleblower Law Insights
December 17, 2010
Report documents extent of drug companies’ frauds
Does it seem as though every day there’s another report of a drug company paying millions to settle allegations of off-label promotion, poor manufacturing practices or overcharging the government?...
Posted In Whistleblower Law Insights
December 16, 2010
Will Wall St. undermine SEC whistle-blower program?
Business lobbyists are working overtime to kill the new Securities and Exchange Commission whistle-blower program in a tried-and-true Washington way: Convince the agency to issue regulations that render...
December 14, 2010
Will GOP slow CFTC’s efforts to transform derivatives market?
The Commodities Futures Trading Commission is facing a lot of hurdles, including a lack of resources. But it has been moving quickly to draft rules mandated by the Dodd-Frank law. That law gave the CFTC...
December 13, 2010
WikiLeaks cable shows surprising new lows in big pharma behavior
If you thought the depths of pharma corruption bottomed out at marketing fraud, pricing fraud or scientific fraud, you’ll be interested in this stunning revelation: Pfizer hired investigators to...
Posted In Whistleblower Law Insights